BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/1/2026 6:45:10 AM | Browse: 5 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 118940
Country China
Category Oncology
Manuscript Type Retrospective Study
Article Title ST2, PIVKA-II, CEA, CA125 and their combinations in elderly liver metastases cancers: Development of a diagnostic scoring model
Manuscript Source Unsolicited Manuscript
All Author List Yun Cheng, Yan-Sha Sun and Yong-Ming He
Funding Agency and Grant Number
Corresponding Author Yun Cheng, Associate Chief Physician, Department of Integrated Traditional Chinese Medicine and Western, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, No. 42 Baiziting, Nanjing 210009, Jiangsu Province, China. chengyun_nj@163.com
Key Words Soluble growth-stimulating gene 2; Protein induced by vitamin K absence or antagonist-II; Carcinoembryonic antigen; Carbohydrate antigen 125; Liver metastasis; Lung cancer; Colorectal cancer; Scoring model
Core Tip Based on the logistic regression analysis, a risk scoring model incorporating soluble growth-stimulating gene 2, protein induced by vitamin K absence or antagonist-II, carcinoembryonic antigen, carbohydrate antigen 125, and fatty liver history was developed to predict liver metastasis in elderly colorectal and lung cancer patients. The soluble growth-stimulating gene 2 + protein induced by vitamin K absence or antagonist-II + carcinoembryonic antigen + carbohydrate antigen 125 combination achieved the optimal diagnostic balance (area under the curve = 0.896), with specificity reaching 98.42%. Risk stratification significantly correlated with metastasis incidence (93.2% in high-risk vs 10.4% in low-risk). This quantitative model provides a simple, non-invasive tool for early identification of high-risk patients, facilitating personalized surveillance and timely intervention.
Citation Cheng Y, Sun YS, He YM. ST2, PIVKA-II, CEA, CA125 and their combinations in elderly liver metastases cancers: Development of a diagnostic scoring model. World J Gastrointest Oncol 2026; In press
Received
2026-01-30 09:48
Peer-Review Started
2026-01-30 09:48
First Decision by Editorial Office Director
2026-02-10 09:01
Return for Revision
2026-02-10 09:01
Revised
2026-02-12 12:12
Publication Fee Transferred
Second Decision by Editor
2026-04-01 02:45
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-04-01 06:45
Articles in Press
2026-04-01 06:45
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com